NewAmsterdam Pharma Warrant
NAMSW
9 hedge funds and large institutions have $26M invested in NewAmsterdam Pharma Warrant in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0.04% less ownership
Funds ownership: 28.22% → 28.18% (-0.04%)
13% less capital invested
Capital invested by funds: $29.9M → $26M (-$3.91M)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$44.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VI
Vestcor Inc
Fredericton,
New Brunswick, Canada
|
-$61.7K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FLSM
1
Frazier Life Sciences Management
Palo Alto,
California
| $10M | – | – | – |
|
|
RCM
2
RA Capital Management
Boston,
Massachusetts
| $6.68M | – | – | – |
|
|
AAA
3
Affinity Asset Advisors
New York
| $4.91M | – | – | – |
|
|
BCLSI
4
Bain Capital Life Sciences Investors
Boston,
Massachusetts
| $2M | – | – | – |
|
|
DM
5
Deerfield Management
New York
| $1.86M | – | – | – |
|
|
AC
6
Aristeia Capital
Greenwich,
Connecticut
| $343K | – | – | – |
|
|
VI
7
Vestcor Inc
Fredericton,
New Brunswick, Canada
| $131K | -$61.7K | -2,966 | -31% |
|
|
WAM
8
Wolverine Asset Management
Chicago,
Illinois
| $42.6K | +$44.2K | +2,127 | New |
|
9
UBS Group
Zurich,
Switzerland
| $7.94K | – | – | – |
|
NAMSW Hedge Fund Activity: Q1 2026 in Review
9 of the 8,143 institutional investors tracked by Wall St. Rank reported a position in NewAmsterdam Pharma Warrant (NAMSW) for Q1 2026, worth a combined $26M — down 13% from $29.9M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NAMSW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $44.2K. The largest seller was Vestcor Inc, cutting an estimated $61.7K.
- 9 institutional investors held NewAmsterdam Pharma Warrant (NAMSW) as of Q1 2026, unchanged from Q4 2025.
- Funds reported $26M of NewAmsterdam Pharma Warrant stock for Q1 2026, down 13% quarter-over-quarter.
- 1 fund opened new NewAmsterdam Pharma Warrant positions in Q1 2026 and 0 closed out, a net change of +1 holder.
- The largest NewAmsterdam Pharma Warrant buyer in Q1 2026 was Wolverine Asset Management, an estimated $44.2K added.
- The largest NewAmsterdam Pharma Warrant seller in Q1 2026 was Vestcor Inc, an estimated $61.7K sold.
Based on aggregated 13F filings for Q1 2026.